InVivoMAb anti-mouse/human IL-5
BE0198
ApplicationsNeutralisation/Blocking, Other Application
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse/human IL-5
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDTRFK5
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Moynihan KD, Opel CF, Szeto GL, et al. Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat Med. 2016,22(12):1402-1410. doi: 10.1038/nm.4200Read this paper
- Griseri T, Arnold IC, Pearson C, et al. Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis. Immunity. 2015,43(1):187-99. doi: 10.1016/j.immuni.2015.07.008Read this paper
- Sanfilippo AM, Furuya Y, Roberts S, et al. Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecF(low) Alveolar Macrophages. Infect Immun. 2015,83(7):2976-83. doi: 10.1128/IAI.00142-15Read this paper
- Shi Y, Tsuboi N, Furuhashi K, et al. Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency. J Immunol. 2014,193(10):5129-39. doi: 10.4049/jimmunol.1401051Read this paper
- Weng M, Baron DM, Bloch KD, et al. Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2011,301(6):L927-36. doi: 10.1152/ajplung.00049.2011Read this paper
